Avidity Biosciences
144 hedge funds and large institutions have $701M invested in Avidity Biosciences in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 47 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
9% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 23
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5.84% less ownership
Funds ownership: 110.3% → 104.46% (-5.8%)
Holders
144
Holding in Top 10
2
Calls
$756K
Puts
$345K
Top Buyers
| 1 | +$16.5M | |
| 2 | +$7.01M | |
| 3 | +$6.43M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.69M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.71M |
Top Sellers
| 1 | -$35.9M | |
| 2 | -$11.2M | |
| 3 | -$7.28M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$6.53M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.43M |